Home ›› Cancer Programs ›› Urological Cancer ›› Clinical Trials ›› Clinical Trial Safeguards

Both conventional care and clinical trials have risks, side effects and benefits that vary depending on the individual. However, there are rigorous guidelines in place to protect the well-being and safety of clinical trial participants. All clinical trials at the FHCI's Clinical Research Center have been reviewed and approved for appropriateness and safety through the Institutional Review Board (IRB), made up of physicians and non-physicians. The investigator conducting the study will explain any known or anticipated risks ahead of time. This information is contained in the informed consent as well. Also, clinical-trial participants are monitored closely to identify any changes in their condition. 

Would you like more information?

For more information or to schedule an appointment, call (407) 303-1700 or click here to fill out an online assistance form.